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Post-operative atrial ﬁbrillation (POAF) is one of the most frequent complications of cardiac surgery and an important predictor of patient
morbidity as well as of prolonged hospitalization. It signiﬁcantly increases costs for hospitalization. Insights into the pathophysiological factors
causing POAF have been provided by both experimental and clinical investigations and show that POAF is ‘multi-factorial’. Facilitating factors
in the mechanism of the arrhythmia can be classiﬁed as acute factors caused by the surgical intervention and chronic factors related to struc-
tural heart disease and ageing of the heart. Furthermore, some proarrhythmic mechanisms speciﬁcally occur in the setting of POAF. For
example, inﬂammation and beta-adrenergic activation have been shown to play a prominent role in POAF, while these mechanisms are
less important in non-surgical AF. More recently, it has been shown that atrial ﬁbrosis and the presence of an electrophysiological substrate
capable of maintaining AF also promote the arrhythmia, indicating that POAF has some proarrhythmic mechanisms in common with other
forms of AF. The clinical setting of POAF offers numerous opportunities to study its mechanisms. During cardiac surgery, biopsies can be
taken and detailed electrophysiological measurements can be performed. Furthermore, the speciﬁc time course of POAF, with the delayed
onset and the transient character of the arrhythmia, also provides important insight into its mechanisms.
This review discusses the mechanistic interaction between predisposing factors and the electrophysiological mechanisms resulting in POAF
and their therapeutic implications.
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Introduction
Atrial arrhythmias and atrial ﬁbrillation (AF) in particular are well-
known complications after cardiac surgery with a reported inci-
dence between 10 and 60%.
1–17 The incidence is higher in patients
undergoing valve surgery than in patients undergoing coronary
artery bypass surgery (CABG).
1,2,7,8,10,11,17,18 Post-operative atrial
arrhythmias also occur after non-cardiac surgery, especially after
oesophagectomy,
19 lung surgery,
20–24 and large abdominal
surgery.
25–27 The incidence after non-cardiac surgery is,
however, lower with incidences ranging from 0.3 to 29%.
22,28,29
Postoperative atrial arrhythmias are associated with prolonged
hospital stay, haemodynamic instability, an increased risk of
stroke, and increased mortality.
2–4,6,10,12,13,24,28,30–33
The exact pathophysiological mechanisms responsible for the
onset and perpetuation of post-operative atrial arrhythmias are
incompletely understood. Factors facilitating post-operative AF
(POAF) can be classiﬁed in acute factors directly related to
surgery (e.g. adrenergic stimulation) and factors that are reﬂecting
a chronic and progressive process of remodelling or ageing of the
heart (e.g. left atrial enlargement).
14,15 These predisposing factors
can on the one hand provoke triggers able to initiate the arrhyth-
mia and on the other hand enhance the development of a sub-
strate capable of perpetuating AF.
The association of POAF with speciﬁc kinds of surgery and the
time course of the arrhythmia can help to better understand its
mechanisms. First, the association of POAF with cardiac surgery
and degree of structural heart disease suggests a direct role for
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occurrence of POAF. Secondly, the arrhythmia follows a speciﬁc
time course. In most studies, the incidence peaks on the second
day after surgery and rapidly declines to around 2% at discharge,
32
suggesting that some of the pro-arrhythmic mechanisms require
some time to become operative. Furthermore, the transient
nature of the arrhythmia suggests a reversible mechanism, caused
by factors which come into play shortly after surgery, but seem
to subside on the long run.
This review discusses the mechanistic interaction between pre-
disposing factors, alterations in intracellular signalling, and the elec-
trophysiological mechanisms of POAF.
Epidemiology
The incidence of POAF after cardiac surgery varies considerably
between different studies (Table 1). This variation in incidence is
due to differences in patient demographics, techniques for
rhythm monitoring and criteria for diagnosis.
5,34 Mathew et al.
3
found diverging POAF incidences according to different regions.
The authors reported a similar POAF incidence among patients
in the USA (33.7%), Canada (36.6%), Europe (34%), and the
Middle East (41.6%), but a lower POAF incidence in South
America (17.4%) and Asia (15.7%).
3 Another example that stresses
the importance of patient demographics is the identiﬁcation of
Caucasian race as an independent predictor of POAF in several
studies.
17,34 Fluctuation in reported POAF incidence due to
differences in rhythm follow-up is illustrated by the comparison
of the following three studies. Siebert et al.
11 found an incidence
as low as 9.8% after isolated CABG. However, only AF occurrence
during stay on the intensive care unit was studied, with a mean
period of 2.3 days.
11 In another example, Leitch et al. found an
incidence of 17.2% after isolated CABG. Again, only during the
ﬁrst 48 h AF and atrial ﬂutter (AFL) were detected by continuous
electrocardiogram (ECG) monitoring. After these 48 h, AF and
AFL were solely identiﬁed if clinical symptoms occurred.
9 On
the other hand, in a large retrospective study Shen et al.
17 found
an incidence of 29% after isolated CABG. In this report, all patients
received continuous 24 h telemetry with arrhythmia-detection
algorithms during their entire hospital stay. The difference in
reported POAF incidence between these studies emphasizes that
a more systematic ECG monitoring results in a better identiﬁcation
and thus a higher detected incidence.
17 Finally, the deﬁnition of
POAF also inﬂuences its reported incidence. For example, in one
study POAF is deﬁned as any documented AF .5 min, while in
another study only episodes of .10 min are counted.
7,16
Despite the methodical differences between studies, the inci-
dence of POAF could be shown to be strongly determined by
the kind of surgery. In general, the reported incidence of POAF
after CABG ranges between 16 and 50%.
4,6,8,9,11–17 The incidence
is higher after valve surgery and highest after a combination of
CABG and valve surgery.
1,2,7,10,11,17,18 Remarkably, after heart
transplantation the incidence of post-operative atrial arrhythmias
is reported to be very low (4%).
35 However, due to the surgical
cut and sew lines in the atria during heart transplantation, the
atrial surface is signiﬁcantly reduced and pulmonary veins are
isolated.
In the group of non-cardiac surgery, the incidence of POAF is
higher after thoracic surgery than after non-thoracic surgical pro-
cedures.
36,37 In non-cardiac, non-thoracic surgery, POAF occurs
relatively infrequently (0.37% for ophthalmic surgery up to 13%
for large colorectal surgery).
25–30 After thoracic surgery POAF is
more frequent, with reported incidences of 9–29%.
20,21,23,24,38–42
Somestudiesreportnodifferencesinincidencebetweenmoreinva-
sive and less invasive types of thoracic surgical procedures,
20,21
although other studies do.
22,38–40
The time course of the onset of POAF after cardiac surgery is
very typical, with 70% of the patients developing POAF in the
ﬁrst 4 post-operative days and only 6% developing AF after the
6th day.
4,7,43 Post-operative atrial ﬁbrillation has its peak incidence
on the 2nd post-operative day and recurrence of POAF is highest
on the 3th post-operative day, with only 22% of the patients
experiencing .2 episodes of POAF.
3,8
Different risk factors for development of POAF after cardiac
surgery have been identiﬁed. The strongest predictor of POAF is
advancing age.
1,2,4,6–9,15–18,44–48 Association with other risk
factors shows a large degree of variability between different
studies (Table 2). For example, Zacharias et al.
47 found body
mass index to be an important determinant of POAF, while
other studies failed to show this.
6,7,15 Furthermore, left atrial enlar-
gement is a predictor of POAF in some studies.
15,46 However,
sometimes left atrial enlargement is not predictive even when
mitral valve surgery in the same study is a risk factor. This might
indicate a role for tissue trauma as a consequence of a more inva-
sive procedure during mitral valve repair/replacement.
3,48
In 2002, Ferguson et al.
49 conﬁrmed the wide-spread perception
among cardiac surgeons that the population of patients currently
referred for isolated CABG are older, sicker, and have a higher sur-
gical risk than a decade ago. As age represents an important risk
factor for the onset of POAF, one would expect an increase in inci-
dence of POAF over time which indeed in one study has been
reported.
1 Other studies, however, failed to identify an increase
or even reported a trend towards a decreasing preva-
lence.
9,10,17,50,51 Whether the lack of increase in POAF incidence
over the past years is due to more frequent use of beta-blockers
or amiodarone is currently unknown. In the study of Shen
et al.,
17 the annual percentage of aortic and mitral valve procedures
increased over two decades. Considering that these surgical pro-
cedures are associated with a higher risk of POAF, and that the
incidence remained approximately 30%, the authors concluded
that some progress in treating POAF has been made.
17
Mechanisms based on acute
factors
Inﬂammation
The similarity between the time course of AF occurrence after
cardiac surgery and the activation of the complement system
with the release of pro-inﬂammatory cytokines suggests an inﬂam-
matory component in the mechanism triggering POAF.
52–57
Complement activation during cardiac surgery with cardiopulmon-
ary bypass (CPB) occurs in two steps. The ﬁrst phase occurs
during CPB, results from interaction of blood with the surface of
B. Maesen et al. 160.............................................................................................................................................................................................................................................
Table 1 Incidence of post-operative atrial ﬁbrillation
Author Fuller et al. Leitch et al. Creswell et al. Aranki et al. Almassi et al. Siebert et al. Mahoney et al. Mathew et al. Villareal et al. Banach et al. Mariscalco et al. Ahlsson et al. Shen et al.
Year of publication 1989 1990 1993 1996 1997 2001 2002 2004 2004 2006 2009 2009 2010
n (% male) 1666 (88.6) 5807 (NS) 3983 (66.7) 570 (69) 3855 (98.4) 821 (74.4) 10550 (71) 4657 (79.8) 6477 (73.8) 1200 (66.6) 9495 (73.2) 571 (78) 10390 (65)
Age (overall) NS 62.2+12.3 67 63.7+9.6 NS NS 61+2.4 66.2+9.5 62.3+12.9
Age (AF group) 60.9+7.3 71 66.8+8.3 67.8 67.9+9.6 66+7.8 69.2+7.6
Study type Prospective Prospective Prospective Prospective Prospective Prospective Retrospective Prospective Retrospective Prospective Retrospective Prospective Retrospective
Multicentre (number) No No No No Yes (14) No No Yes (70) No Yes(12) No No No
Deﬁnition of POAF AF detected by
continuous telemetry
detected by
continuous
monitoring (48 h)
or by
clinical symptoms
and signs
New onset AF,
AFL, PAT
AF requiring
medication/pacing
NS Any AF detected via
continuous ECG
monitoring (only)
during intensive care
unit stay
NS Entry in case report
form/AF detected by
ECG
AF of any duration,
any time based on
ECG
NS AF–AFL.15 min ECG veriﬁed
episode .1m i n
during ﬁrst 7
days
AF(L) during
post-operative
recovery period
and
requiring treatment
CPB (% of patients) 100 100 100 100 100 85.6 (703/821) 100 NS 87.5 100 93.9 NS
History of AF None None None None None None None 0.09% (424/4657) None NS (28%
arrhythmias)
None None None
Incidence of POAF (%) 28.4 17.2 34.6 (1378/
3983)
33 29.6 (1143/
3885)
NS NS 32.3 (1503/4657) 16 23.2 26.7 28.9 30
CABG Alone 28.4 (476/1666) 17.2 31.9 (905/2833) 33 27.6 9.8 (64/650) 17.7 30.9 (1349/4371) 16 (994/6477) 23.2 (278/1200) 22.9 28.9 (165/571) 29 (2098/7284)
OPCAB 10.2 (12/118)
CABG+AVR 60.1 (95/158) 36.4 25.0 (9/36)
|33.8 |53.9 (154/286) |45.2 |49 (436/887)
CABG+MVR 63.1 (65/103) 60 17.6 (3/17)
AVR 48.8 (83/170) 32.9
|24.6 |39.8 |33 (459/1399)
MVR 44.3 (43/97) 48.8
Transplantation 11.0 (15/136)
Table showing incidences for POAF in different studies.
n, number of patients included; CABG, coronary artery bypass grafting; AVR, aortic valve replacement, MVR, mitral valve repair/replacement, NS, not stated; CPB, cardiopulmonary bypass; AFL, atrial ﬂutter; PAT, paroxysmal atrial tachycardia;
OPCAB, off-pump coronary artery bypass.
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Table 2 Risk factors for post-operative atrial ﬁbrillation
Author Fuller
et al.
Leitch et al. Creswell
et al.
Aranki et al. Almassi et al. Zaman et al. Hakala et al. Mathew et al. Auer et al. Zacharias et al. Banach et al. Shen et al.
Year of publication 1989 1990 1993 1996 1997 2000 2002 2004 2005 2005 2006 2010
Number of
Patients
1666 5807 3983 570 3855 326 88 4657 253 8051 1200 10390
Risk Factors
Age P ¼ 0.0001 OR ¼ 1.7,
P,0.001 (10 yr
decile)
P , 0.001 OR ¼ 2.0
P ¼ 0.002 (age 70
to 80 yr)
OR ¼ 1.61
P ¼ 0.0001 (10 yr
decile)
OR ¼ 1.53
P , 0.0005 (per 5 yr
increase)
OR ¼ 1.07,
P ¼ 0.02 (each
increasing yr above
lower border)
OR ¼ 1.75
P , 0.001 (10 yr
decile)
OR ¼ 2.6,
P , 0.01 (above
vs. below median)
OR ¼ 1.52
P , 0.001 (10 yr
decile)
OR ¼ 2.6
P , 0.001
(age.70 yr)
OR ¼ 5.34
(age.72 yr)
History of AF OR ¼ 2.11,
P , 0.001
OR ¼ 6.1,
P , 0.002
COPD OR ¼ 1.5,
P ¼ 0.006
P , 0.001 ns OR ¼ 1.37,
P ¼ 0.0016
ns OR ¼ 1.43,
P ¼ 0.009
OR ¼ 1.28,
P , 0.001
ns ns
Hypertension ns ns ns OR ¼ 1.6,
P ¼ 0.03
OR ¼ 1.19,
P ¼ 0.027
ns ns ns ns ns OR ¼ 1.15
Male gender P ¼ 0.02 ns OR ¼ 1.7,
P ¼ 0.01
ns OR ¼ 2.88,
P ¼ 0.009
ns ns ns OR ¼ 1.24,
P ¼ 0.001
ns ns
Diabetes ns ns ns ns ns ns ns ns ns ns
Prior MI ns ns OR ¼ 1.6,
P ¼ 0.01
ns ns ns ns ns
CHF ns ns ns ns OR ¼ 4.8,
P , 0.005
OR ¼ 1.28
BMI ns ns ns OR ¼ 1.36,
p , 0.001
BMI ¼ .30–
35 kg/m2
ns
No pre-operative
ß-blocker therapy
ns OR ¼ 1.2,
P ¼ 0.011
ns ns ns ns ns OR ¼ 1.7,
P , 0.05
OR ¼ 1.17,
P ¼ 0.005
OR ¼ 0.79,
P , 0.01
ns
Left atrial enlargement ns OR ¼ 1.29,
P ¼ 0.01
ns
RCA stenosis ns ns ns ns
Mitral valve surgery OR ¼ 2.86,
P ¼ 0.0001
OR ¼ 1.74,
P , 0.001
OR ¼ 2.8,
P , 0.01
OR ¼ 2.42,
P , 0.001
OR ¼ 1.91
Postoperative
withdrawal of
ß-blocker
ns OR ¼ 1.91,
P , 0.001
Postoperative
withdrawal of ACE-I
OR ¼ 1.69,
P , 0.001
(No) post-operative
ß-blocker therapy
P ¼ 0.001 ns OR ¼ 0.32,
P , 0.001
OR ¼ 0.79,
P , 0.01
Postoperative ACE-I
therapy
OR ¼ 0.62,
P , 0.001
This table shows an overview of risk factors for POAF in different studies. The numbers in the boxes are statistical values (P value, odds ratio, relative risk). ns means not signiﬁcant after multivariate analysis. If risk factors are not mentioned in
the study, the boxes are empty.
COPD, chronic obstructive pulmonary disease, ACE-I, angiotensin-converting enzyme inhibitor; RCA, right coronary artery; MI, myocardial infarction; CHF, chronic heart failure, yr¼year.
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2the extracorporeal circuit, and is mediated via the ‘alternative
pathway’ involving tumour necrosis factor a. The second phase
acts via the ‘classical pathway’ which is initiated by protamine
usually administered after CPB. Interestingly, fever and POAF do
not occur before the ﬁrst post-operative days and thus coincide
with the second phase rather than with the ﬁrst. Their time
course corresponds to changes in activity of markers indicating
complement activation and inﬂammation, such as C-reactive
protein (CRP), complement-CRP complexes,
52 interleukin-2,
58
and interleukin-6.
53 The similarity in the post-operative time
course of POAF incidence and CRP is illustrated in Figure 1.
Also, a more pronounced increase in post-operative white blood
cell count as a marker of inﬂammatory response independently
predicts the development of post-operative AF in some studies,
but not in others.
56,59 Furthermore, patients developing POAF
have up-regulated monocyte activation and higher monocyte and
neutrophil levels post-CPB.
60,61
Besides the systemic inﬂammatory reaction caused by use of
CPB, also local inﬂammation caused by surgical incision contributes
to the occurrence of POAF. It is known that the degree of atrial
inﬂammation increases with the invasiveness of surgery, but even
after pericardiotomy alone the atrium becomes mildly inﬂamed.
This transient sterile pericarditis, which is part of the healing
process, might help to explain the temporal occurrence of
POAF. Comparison of AF incidence after off-pump and on-pump
surgery facilitates to distinguish the importance of systemic inﬂam-
mation from that of surgical incision and manipulation. As such,
off-pump CABG (OPCAB) is believed to elicit less systemic inﬂam-
mation than on-pump surgery because of reduced cytokine
responses and less myocardial injury.
62 However, several studies
failed to show statistical association between OPCAB and a
lower incidence of POAF.
11,63–68 This lack of association suggests
that surgical stress as such is a more important determinant than
systemic inﬂammation in triggering POAF. It has to be noted,
however, that some of these studies are limited by their retrospec-
tive nature and sample size, and that they all showed at least a non-
signiﬁcant trend towards lower AF incidence in off-pump surgery.
Other controlled randomized studies do reveal CPB in combi-
nation with cardioplegic arrest as the main predictor of POAF,
especially in elderly and high-risk individuals.
69–72 For example,
Panesar et al.
73 performed an extensive meta-analysis including
4921 patients aged 70 years and older and reported a signiﬁcantly
lower AF incidence in the OPCAB group compared with on-pump
surgery. It could be argued that the inﬂuence of on-pump surgery
compared with off-pump surgery on AF occurrence is rather small
and that this effect only emerges in the older patient population,
where the risk of POAF is known to be higher.
1–4 Furthermore,
minimal invasive OPCAB resulted in lower AF incidence compared
with conventional, more extensive OPCAB in one study, but sur-
prisingly failed to reach signiﬁcance in another.
74,75 This might indi-
cate that the trauma and the successive inﬂammation of the
pericardium that easily spreads within the pericardial sac rather
than the manipulation of the myocardial tissue itself renders the
atria more prone to AF.
Several experimental and clinical studies have been undertaken
to explore how inﬂammation enhances AF susceptibility of atrial
tissue. A prominent example of involvement of inﬂammation in
the development of AF is the study by Frustaci et al.
76, showing
lymphomononuclear inﬁltrates compatible with atrial myocarditis
in atrial tissue of 66% of patients with lone AF.
76 Also Chen
et al.
77 found CD45-positive cells to be independently and signiﬁ-
cantly higher in right atrial appendages of patients with AF com-
pared with patients with sinus rhythm. An excellent
experimental model to study post-operative AF/AFL is the
canine sterile pericarditis model of Page et al.
78 In this model,
sterile pericarditis is created by epicardial application of sterile
talcum. The time course of atrial arrhythmias in patients after
open heart surgery is consistent with inducibility of AF/AFL in
this model, both peaking between day 2 and 4 after surgery.
79 In
response to sterile pericarditis, proliferation, and activation of epi-
cardial ﬁbroblasts takes place in the atria, with loss of epicardial
myocytes and altered distribution of connexins 40 and 43.
80
These changes are associated with non-uniform slowing of conduc-
tion and promote induction and maintenance of AF/AFL. The
causative association between inﬂammation and post-operative
AF/AFL was further studied in the canine pericarditis model by
suppression of the inﬂammatory response with steroids and
HMG-CoA reductase inhibitors (statins).
81,82 Administration of
prednisone inhibited tissue inﬂammation and reduced serum
CRP and AF inducibility.
81 Also atorvastatin, an HMG-CoA
reductase inhibitor, signiﬁcantly reduced CRP levels and AF dur-
ation, and attenuated perimyocarditis.
82 Finally, the use of n-3 poly-
unsaturated fatty acids in the sterile pericarditis model was
associated with lower levels of inﬂammatory markers, a reduction
in AF inducibility and AF duration, prolongation of the refractory
period, and shortening of intra-atrial conduction times.
83
Atrial inﬂammation is known to cause conduction disturbances.
For example, in a study with mongrel canines, Ishii et al.
84
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Figure 1 Time course of atrial ﬁbrillation incidence after
cardiac and non-cardiac surgery and time course of C-reactive
protein after cardiac surgery. Atrial ﬁbrillation incidence after
non-cardiac surgery peaks at post-operative day 1 and then
rapidly declines to 2% at day 6, while atrial ﬁbrillation incidence
after cardiac surgery peaks at post-operative day 2 and slowly
declines to around 6 % at day 6. This suggests a ‘cardiac factor’,
related to the speciﬁc setting of cardiac surgery. The time
course of C-reactive protein is surprisingly similar to that of
atrial ﬁbrillation incidence after cardiac surgery, supporting the
role for inﬂammation in the mechanism of post-operative atrial
ﬁbrillation (modiﬁed from references
4,30,52).
Post-operative atrial ﬁbrillation 163measured myeloperoxidase activity and neutrophil cell inﬁltration
in atrial myocardium. The degree of atrial inﬂammation was associ-
ated with a proportional increase in the heterogeneity of atrial
conduction after experimental cardiac surgery and increased the
incidence and duration of AF.
84 In another canine study, acute
inﬂammation provoked by arachidonic acid produced slowing
and enhanced anisotropy of conduction but did not affect atrial
refractoriness.
85
In several clinical trials, drugs with anti-inﬂammatory effects have
shown to be effective in lowering AF incidence after CABG and/or
valve surgery. Corticosteroids reduce the incidence of new-onset
POAF by inhibition of cytokine release (tumour necrosis factor a
and interleukin-6), thereby reducing complement activation.
86,87
A recent meta-analysis of 17 643 patients undergoing cardiac
surgery suggests that pre-operative use of statins signiﬁcantly
reduces POAF incidence.
88 The exact mechanism by which statins
lower POAF incidence is, however, likely pleiotropic. Besides its
lipid-lowering effect, pre-operative statin therapy is known to
decrease inﬂammation markers,
89 and also to attenuate myocardial
reperfusion injury after cardiac surgery.
90 According to the Euro-
pean guidelines, corticosteroids (class IIb recommendation) may
be and statins (class IIa recommendation) should be considered
for prevention of POAF after CABG and/or valve surgery.
91 Treat-
ment with n-3 polyunsaturated fatty acids to prevent POAF has
been reported with success in some studies;
92,93 however, placebo-
controlled, double-blinded, randomized trials have failed to repro-
duce this protective effect of ﬁsh oil.
94,95
Finally, it is known that chronic inﬂammation in patients can cause
atrial structural remodelling. C-reactive protein is associated with
and predicts patients at risk of developing future non-surgical
AF.
54,55 This chronic inﬂammation might also predispose to the
occurrence of POAF. Some studies found elevated pre-operative
CRP levels to be associated with an increased risk of the arrhyth-
mia after CABG.
32,96 Others, on the contrary, failed to ﬁnd an
association between pre-operative CRP and POAF.
60,97,98 This
controversy suggests that the induction of inﬂammation during
surgery, rather than a pre-existing inﬂammation process, contrib-
utes more to the development of the arrhythmia.
Sympathetic activation
In the heart, sympathetic stimulation is mediated by
b-adrenoreceptors and leads to an increase in heart rate and con-
tractile force, but also to enhanced excitability and automaticity.
99
Several ﬁndings support a role for sympathetic activation in the
pathogenesis of atrial arrhythmias after cardiac surgery. Advanced
age, the most important risk factor for POAF, is associated with
increasing circulating norepinephrine levels.
100 Patients who
develop POAF also have signiﬁcantly elevated norepinephrine
levels post-operatively compared with patients without POAF.
14
This association is further reﬂected by the fact that the onset of
POAF is preceded by an increase in sinus rate and atrial ectopic
activity. Also, studies on post-operative heart rate variability
(HRV) showed an increase in time- and frequency-domain par-
ameters of HRV prior to the onset of POAF, consistent with
increasing sympathetic activity.
101,102 However, controversy
remains if this sympathetic activation is accompanied by either
increased activity or loss of vagal tone.
101–103 Finally, sympathetic
activation has been reported to shorten atrial refractoriness non-
uniformly, thereby favouring the perpetuation of the arrhythmia.
104
On the other hand, there is a slight discrepancy between the peak
of sympathetic activation, which occurs within 24 h post-
operatively, and the onset of POAF, mostly developing between
48 and 72 h after surgery.
105
If sympathetic activation plays an important role in onset of
POAF, one would expect that cardiac denervation reduces the
incidence of the arrhythmia. This was ﬁrst studied by Melo
et al.
106 They performed ventral cardiac denervation in 207
patients undergoing low-risk CABG, and indeed found that this
intervention signiﬁcantly reduced the incidence and severity of
POAF.
106 It should be noted, however, that only 15% of the
patients in their study underwent telemetric monitoring and
some patients with asymptomatic AF might not have been ident-
iﬁed. Other studies failed to show the beneﬁt of cardiac denerva-
tion or found even an increase in POAF.
107–109 These ﬁndings,
however, do not exclude a role for sympathetic activation in the
arrhythmia substrate, as both sympathetic and parasympathetic
activation alter atrial refractoriness.
109,110 Hogue et al.
103 detected
a higher HRV in some patients, but a lower HRV in others in the
hour before onset of POAF, suggesting the possibility of divergent
autonomic conditions shortly before onset of the arrhythmia.
Cardiac denervation obviously interrupts both sympathetic and
parasympathetic regulation of heart function.
Drugs mimicking sympathetic activation are also pro-arrhythmic.
Administration of milrinone, a phosphodiesterase inhibitor that
increases cardiac cyclic adenosine monophosphate (cAMP), dobu-
tamine, and dopamine, both binding on the b-adrenoreceptor, is
associated with an increased incidence of POAF.
111–113 Activation
of protein kinase A by cAMP can lead to stimulation of multiple
cardiac currents, including the L-type calcium current (ICaL),
thereby promoting the occurrence of early and delayed afterdepo-
larizations.
114,115 Mechanisms by which inotropic drugs can
promote POAF consist of abbreviation of atrial refractoriness
(presumably due to activation of the slowly activating delayed
rectiﬁer current (IKs)) and increased ectopic activity.
114–116
In theory, blocking the sympathetic activation by
b-adrenoreceptor blocking drugs should reduce the incidence of
POAF. Indeed, patients receiving b-blockers post-operatively
have fewer episodes of AF compared with patients receiving
placebo.
50,117,118 However, these results must be interpreted
with caution as arrhythmia detection varies between studies and
some of the patients, assigned to the placebo group, were with-
drawn from their pre-operative b-blocker therapy.
105 The withdra-
wal of pre-operative b-blockade after CABG is associated with a
more than two-fold increase in POAF.
119 The peak effect of this
rebound phenomenon correlates well with the time course of
POAF, suggesting that the continuity of pre-operative b-blocking
therapy after surgery has a stronger reductive effect on POAF inci-
dence than b-blocking treatment started de novo after surgery.
14
The increase in POAF incidence after b-blocker withdrawal
might be due to the synergistic effect of the rebound phenomenon
and the higher sympathetic tone post-operatively.
Workman et al.
50 found pre-operative b-blockade to be associ-
ated with signiﬁcant prolongation of atrial cell action potential dur-
ation (APD) and atrial effective refractory period (AERP) in
B. Maesen et al. 164isolated cells of patients undergoing open heart surgery.
120 The
authors called this adaptive response ‘pharmacological remodel-
ling’, as it appeared to be caused by the previous exposure to
but not by the acute presence of b-blocker. Contribution of this
prolongation of refractoriness to the anti-arrhythmic effect of
b-blockers can act via lengthening the minimum pathlength for
reentry. In their study, however, this b-blocker-induced AERP pro-
longation was identical between patients who did and did not
developed POAF.
50 The authors concluded that, as pre-operative
b-blockade did reduce POAF incidence in their study without
involvement of b-blocker-induced AERP prolongation, attenuation
of triggered atrial extrasystoles may also underlie the anti-
arrhythmic effect of b-blockers.
50
In conclusion, it seems that sympathetic activation, by altering
atrial refractoriness and promoting ectopic activity, contributes
to the onset of POAF. The fact that b-blockade does not abolish
all episodes of POAF once more stresses the multifactorial aetiol-
ogy of POAF.
121 However, oral b-blocker therapy started at least 1
week before surgery remains the ﬁrst choice in preventing POAF
after cardiac surgery.
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Oxidative stress
Oxidative stress occurs from an imbalance between pro-oxidants
and antioxidants in favour of pro-oxidants. The use of CPB in
cardiac surgery involves controlled ischaemia followed by reperfu-
sion of the heart. During reperfusion, increased production of
reactive oxygen species takes place, leading to myocardial stunning,
tissue damage, and cell death.
122,123
The interaction between oxidative stress and electrical remodel-
ling has been studied in experimental studies. In a canine rapid
atrial pacing (RAP) model of AF, pacing-induced reduction of
AERP was attenuated by ascorbate, a potent antioxidant.
124 Pro-
duction of atrial peroxynitrite, a free radical, was enhanced while
endogenous atrial ascorbate levels were diminished during RAP.
Supplementation of vitamin C prevented atrial tissue ascorbate
depletion and the increased peroxynitrite formation. These
results suggest a direct effect of oxidative stress on early electrical
remodelling (24–48 h after RAP).
124 In another canine RAP study,
AF promotion after 7 days of RAP was attenuated by simvastatine
but not by antioxidant vitamins C and E.
125 The dosages in both
studies were comparable. Therefore, these results might indicate
that vitamin C can attenuate AF promotion in very early remodel-
ling, but that it loses its protective effect during later stages of the
electrical remodelling process. The fact that simvastatine attenu-
ated AF promotion can be partly due to an anti-inﬂammatory
mechanism. As discussed before, statins possess antioxidant as
well as anti-inﬂammatory properties.
126
Atrial myocytes of patients with persistent AF show oxidative
damage following cardiac production of peroxynitrite, which oxi-
dizes cellular lipids, proteins, and DNA and promotes death of car-
diomyocytes via necrosis/apoptosis.
127 This oxidation contributes
to the loss of ﬁbrillar protein function and thus to atrial contractile
dysfunction. Moreover, atrial nicotinamide adenine dinucleotide
phosphate (NADPH) oxidase activity is increased in right atrial
appendages of patients with non-surgical forms of AF compared
with patients without AF.
128 Nicotinamide adenine dinucleotide
phosphate oxidase is known to be an important source of reactive
oxygen species in human atrial myocytes.
128 Direct measurement
of free radicals in atrial tissue of patients during episodes of
POAF is impossible. Therefore, evidence for the role of oxidative
stress has been obtained by measuring concentrations of antioxi-
dants as lipid peroxidation products and by administering antioxi-
dant substances.
129,130
Indications that oxidative stress plays a role in the occurrence of
POAF can be summarized as follows. First of all, reperfusion of
patients undergoing CABG results in oxidative stress and the
amount of oxidative stress depends on the severityof the ischaemic
period and left ventricular ejection fraction.
129,130 Secondly,
Ramlawi et al.
131 conﬁrmed that patients with POAF, compared
with patients without the arrhythmia, have a larger increase in sys-
temic oxidative stress as well as at the myocardial level. Third, in a
follow-up study Kim et al.
132 measured NADPH oxidase activity in
right atrial appendage samples from patients undergoing CABG.
The authors identiﬁed NADPH oxidase activity as the most impor-
tant independent predictor of POAF. Surprisingly, in their prelimi-
nary data there was no difference in NADPH oxidase activity
before CPB and after reperfusion. They hypothesized that the peri-
operative inﬂammatory response, rather than ischaemia and reper-
fusion, stimulates atrial NADPH oxidase activity, thereby increasing
oxidative stress. Interestingly, also Clermont et al.
133 argue that oxi-
dative stress related to myocardial ischaemia/reperfusion might be
overwhelmed by systemic radical activation, which is due to the
activation of neutrophils and high-oxygen tension level during CPB.
The involvement of oxidative stress in the multifactorial mech-
anism of POAF has been further studied by administrating antiox-
idant drugs to patients undergoing heart surgery. Indeed,
antioxidant drugs are reported to lower the incidence of POAF
after cardiac surgery involving CPB use. For example, Carnes
et al.
124 showed that administration of ascorbate to patients under-
going CABG decreased the incidence of POAF. Moreover, combi-
nation of ascorbic acid and b-blockers seems to be more effective
than b-blockers alone in reducing post-CABG AF.
134 Another
example is the administration of the antioxidant N-acetylcysteine.
N-acetylcysteine lowered the incidence of POAF after CABG
and/or valve surgery signiﬁcantly.
135 By scavenging reactive
oxygen species with N-acetylcysteine, myocardial oxidative stress
is attenuated in patients undergoing CABG with CPB and cardio-
plegic arrest.
136 Furthermore, nitric oxide (NO) gas has been
reported to signiﬁcantly inhibit oxidative stress when administered
to patients undergoing CABG.
137 Sodium nitroprusside (SNP), an
NO donor, signiﬁcantly lowered the incidence and duration of
post-CABG AF in a recent pilot study.
138 Finally, also statins are
known to lower the incidence of POAF, presumably in part
through their antioxidative properties.
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Another argument supporting a causative relation between oxi-
dative stress and POAF is the higher occurrence of the arrhythmia
in the elderly.
4 Ageing hearts are more susceptible for ischaemia/
reperfusion injury.
139 It can be hypothesized that cellular damage
due to oxidation is more important in older patients undergoing
cardiac surgery and that this, in part, explains the higher incidence
of POAF in this population.
Finally, the relation between the speciﬁc setting of off-pump
surgery and oxidative stress has also been studied. Off-pump
surgery not only allows avoidance of ischaemia/reperfusion, but
Post-operative atrial ﬁbrillation 165has also been associated with a reduced systemic inﬂammatory
reaction.
62 Furthermore, inﬂammation seems to be at least as
important as ischaemia/reperfusion in producing oxidative radicals
during on-pump surgery.
132,133 Indeed, some studies indicate that
off-pump surgery is associated with less oxidative stress. For
example, Fontaine et al.
140 reported that only plasmas isolated
after on-pump, but not after OPCAB, induce superoxide gener-
ation in the vascular wall of rat aorta, leading to oxidative stress.
Moreover, levels of oxidative stress markers (lipid hydroperoxides,
protein carbonyls, and nitrotyrosine) in peripheral plasma of
patients undergoing CABG were signiﬁcantly lower in OPCAB
compared with on-pump CABG.
141 In another study, Orhan
et al.
142 found reduced systemic inﬂammation in patients under-
going OPCAB compared with on-pump CABG. However, they
failed to show a reduction in myocardial oxidative stress in the
off-pump group.
142
Mechanisms based on pre-existing
factors
Presence of a substrate
Besides AF promotion by acute, surgery-induced factors (Table 3),
also the pre-existence of a substrate for AF can predispose to
onset of the arrhythmia in the post-operative setting (Table 4).
Development of such an AF substrate can involve (A) ion channel
alterations resulting in shortening and/or enhanced dispersion of
atrial refractoriness and (B) heterogeneities in conduction due to
interstitial alterations like, for example, accumulation of collagen
ﬁbres, inﬂammatory inﬁltration or amyloidosis. Both mechanisms
and their relationship with POAF will be separately discussed.
A. Alterations in electrical ion channels as predisposing
factor for POAF
The question as to whether propensity to POAF can be explained
by pre-existing alterations of ion-channel function in these patients
has been addressed by several investigators.
Calcium (Ca
2+) inﬂux through the L-type Ca
2+ channels is the
main current to produce the plateau phase of the atrial action
potential. High atrial rates as they occur during AF or RAP are
known to down-regulate ICaL which contributes to shortening of
atrial refractoriness as a consequence of AF.
143 Some studies have
investigated whether changes of this current can also predispose
to AF in the setting of cardiac surgery. In a study by Van
Wagoner et al.,
144 ICaL in isolated atrial myocytes of non-AF
patients was larger in patients developing POAF compared with
those without the arrhythmia. Also, a higher sympathetic tone
after surgery
14 will further increase calcium inﬂux through L-type
Ca
2+ channels. Enhanced calcium load might elicit triggered activity
(e.g. delayed afterdepolarizations) potentially initiating POAF.
144
However, a more recent and very detailed study by Workman
et al.
50 could not conﬁrm any differences in ICaL between patients
with and without POAF. This recent study and the signiﬁcant
overlap in the Ca
2+ current density data for most patients in the
...............................................................................................................................................................................
Table 3 Overview of studies with important ﬁndings regarding the role of acute surgery-induced factors in the
mechanism of post-operative atrial ﬁbrillation
Author, year Acute factor Species Main ﬁnding
White (1984) Adrenergic Activation Human Prophylactic use of timolol after CABG decreases frequency and severity of
supraventricular arrhythmias.
Kalman (1995) Adrenergic Activation Human Signiﬁcant association between norepinephrine levels and the development of
POAF
Bruins (1997) Inﬂammation Human The second phase of complement activation during CPB involves CRP and is
associated with POAF
Frustaci (1997) Inﬂammation Human Lymphomononuclear inﬁltrates compatible with atrial myocarditis in atrial tissue of
66% of patients with lone AF
Carnes (2001) Oxidative stress Canine/
human
Ascorbate attenuates rapid pacing-induced atrial ERP shortening and decreases the
incidence of POAF after CABG.
Kumagai (2004) Inﬂammation/oxidative
stress
Canine Atorvastatin prevents AF by inhibiting inﬂammation in the sterile pericarditis model
Shiroshita-Takeshita
(2004)
Oxidative Stress/
inﬂammation
Canine AF promotion by atrial tachycardia is attenuated by simvastatin, but not by
antioxidant vitamins.
Ishii (2005) Inﬂammation Canine Atrial inﬂammation after cardiac surgery is associated with inhomogeneity of atrial
conduction
Workman (2006) Adrenergic activation Human Chronic b-blocker therapy is associated with reduced POAF incidence, unrelated
to pre-operative ERP-prolonging
Kim (2008) Oxidative stress Human NADPH oxidase activity in right atrial appendage is the most important
independent predictor of POAF.
Fleming (2008) Adrenergic Activation Human Perioperative milrinone use is associated with an increased incidence of POAF
Ozaydin (2008) Oxidative stress Human Treatment with N-acetylcysteine, an antioxidant, decreases the incidence of
post-operative AF.
Ho (2009) Inﬂammation Human Corticosteroid prophylaxis is effective in reducing the risk of atrial ﬁbrillation
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144 suggest that changes in L-type Ca
2+ channel might
have contributed to POAF initiation in some patients, but certainly
not in all.
Potassium (K
+) channels, which are altered in patients with per-
sistent AF, are apparently not involved in the occurrence of POAF.
First, Brandt et al.
145 reported that the ultra-rapid delayed rectiﬁer
K
+ current (IKur) is reduced in human persistent AF. In non-AF
patients developing AF after cardiac surgery, however, only a
non-signiﬁcant trend towards a decrease in IKur and no difference
in the transient outward K
+ current (Ito) were detected compared
with patients without POAF.
145 Dobrev et al.
146,147 found the
larger basal inward rectifying K
+ current in patients with persistent
AF to consist of increased activity of the inward rectiﬁer K
+
current (IK1) and constitutive activity of the acetylcholine-activated
K
+ current (IK,ACH). Again, both IK1 and IK,ACH were not altered in
non-AF patients developing POAF compared with patients not
having AF after surgery. Thirdly, Workman et al.
50 found no differ-
ences in Ito,i nIK1, or in the sustained outward K
+ current (ISUS)
betweenpatientswhodidanddidnotdevelopPOAF.Theseﬁndings
are consistent with unaltered APD or ERP in their study
50 and with
results in other reports.
145,147 Finally, a recent study of Swartz
etal.
148conﬁrmedthelackofdifferenceinK
+channelsinatrialbiop-
siesofpatientswhodidanddidnotdevelopAFaftercardiacsurgery.
Altogether, these data suggest that, unlike in persistent AF, pre-
operative changes in cellular Ca
2+ and K
+ channels do not play an
important role in the occurrence of POAF.
B. Alterations of the atrial interstitium and extracellular
matrix predisposing to POAF
Ageing is an important risk factor for POAF and slowing of
conduction is known to occur as atria structurally remodel with
age. Spach and Dolber
149 were the ﬁrst to report that progressive
electrical uncoupling of the side-to-side connections between
parallel-orientatedatrialﬁbresoccursinatrialmusclewithadvancing
age. This uncoupling results in a decrease of transverse conduction
and enhances anisotropy of conduction velocity.
149 Such an altera-
tioninconductionisoftenassociatedwiththepresenceofextensive
collagenous septa and favours reentry.
149 The relationship between
this age-dependent remodelling and the occurrence of POAF is
strengthened by several studies. First, Ad et al.
150 reported that
the severity of pre-operative atrial myolysis in right atrial biopsies
of non-AF patients undergoing CABG correlated well with the
occurrence of POAF. In this study and in a study by Mariscalco
et al.,
151 no histological differences were noted in atrial specimens
before and after CPB. This suggests that any contribution of CPB
to POAF must be independent from histological changes. Secondly,
Aketal.
152foundthatpre-operativemorphologicalterationssuchas
atrial myocardial vacuolization and increased myocardial apoptosis
may constitute a pathologic substrate for post-operative AF. Third,
a study of Goette et al.
153 further strengthens this role for pre-
existent structural alterations. In this report, the incidence of
POAF increased with the amount of ﬁbrosis in right atrial appen-
dages of patients undergoing cardiac surgery. Moreover, atrial ﬁbro-
sis was not only age dependent, but also correlated with P-wave
duration suggesting macroscopic slowing of conduction.
153 Finally,
alargeramountofﬁbrosiswasfoundinleftatriaofpatientsdevelop-
ing POAF.
148 On the other hand, one study reported no differences
inrightatrialhistologybetweenpatientswhodoanddonotdevelop
POAF.
154
By comparing POAF incidences between different types of
cardiac surgery, the important contribution of atrial structural
alterations to the mechanisms of POAF is further supported. For
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Table 4 Overview of studies with important ﬁndings regarding the pre-existence of a substrate in the mechanism of
post-operative atrial ﬁbrillation
Author, year Substrate factor Species Main ﬁnding
Steinberg (1993) Structural alteration Human Signal-averaged surface P-wave duration is a potent, accurate, and independent predictor of
POAF
Von Wagoner
(1999)
Alteration in ion
channels
Human Positive correlation between ICaL measured at the time of surgery and the occurrence of
POAF.
Brandt (2000) Alteration in Ion
channels
Human No difference in Ito and a non-signiﬁcant trend towards a decrease in Ikur between patients
with and without POAF.
Ad (2001) Structural alteration Human Atrial myolysis and lipofuscin levels identiﬁed as an independent histologic ﬁnding associated
with POAF
Goette (2002) Structural alteration Human Amount of atrial ﬁbrosis in association with prolongation of the surface P-wave or ageing
correlates with POAF
Dobrev (2002) Alteration in Ion
channels
Human Atrial myocytes of patients developing POAF have no alterations in IK1 and IK,ACH.
Ak (2005) Structural alteration Human Degree of atrial myolysis and increased apoptotic pattern are signiﬁcant predictors for
development POAF.
Mariscalco (2006) Structural alteration Human Atrial histology is similar in patients undergoing on- or off-pump surgery and is similar before
and after CPB.
Workman (2006) Alteration in ion
channels
Human No differences in ICaL, Ito, IK1, and ISUS in right atrial biopsies of patients who do and do not
develop POAF
Kanagaratnam
(2008)
Structural alteration Human Only patients with sustained induced AF develop POAF and have prolonged unipolar
electrograms.
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155 found more profound structural changes in
patients with mitral valve disease than in patients undergoing
CABG: larger atria, hypertrophied cells, more interstitial ﬁbrosis,
and signs of cellular degeneration. Left atrial ﬁbrosis was more pro-
nounced in patients undergoing mitral valve surgery compared
with patients undergoing CABG, independently of the underlying
heart rhythm. It appears reasonable to assume that the higher
AF incidence after mitral valve surgery is due to these structural
alterations. Also, Asher et al.
156 found left atrial enlargement to
be a independently associated with POAF in patients undergoing
only valve surgery.
Other studies more directly demonstrate the pre-existence of
an arrhythmogenic substrate in patients who do develop POAF.
For example, Lowe et al.
45 screened patients at risk for developing
POAF by electrical stimulation of the mid–right atrium during
surgery. Of a total of 36 patients in whom AF was inducible, 17
patients developed POAF. One patient was not inducible, but did
develop POAF. Another example is the study by Kanagaratnam
et al.,
157 where AF was induced during cardiac surgery by burst
pacing in patients without a history of AF. Only patients with sus-
tained induced AF developed any episodes of POAF.
157 Also in the
same study, patients with sustained AF had prolonged unipolar
electrograms compared with patients not able to sustain AF and
this prolongation was more marked in the region of the crista ter-
minalis than in the trabeculated right atrium. The authors stated
that this prolongation of local electrograms is suggestive of micro-
scopic conduction abnormalities.
157 Finally, connexin 40
expression, one of the three connexins present in atrial myocytes,
is signiﬁcantly higher in patients who develop POAF compared
with sinus rhythm patients.
158 Cell-to-cell conduction properties
are determined by gap junctions, which are clusters of transmem-
brane channels built up from connexins. As such, enhanced
expression and heterogeneous distribution of connexin 40 could
result in local conduction heterogeneities.
158
Some indirect evidence for the existence of a structural sub-
strate for AF comes from studies investigating surface-ECG par-
ameters in patients with POAF. In a study of Steinberg et al.,
159
measurement of P-wave duration on the standard ECG was
longer in patients with POAF, but this did not reach signiﬁcance.
In the same study, however, signal-averaged P-wave duration
proved to be an independent predictor of AF after cardiac
surgery.
159 In another study, increase in P-wave dispersion post-
operatively predicted POAF after CABG.
160
The concept of a pre-existing substrate for AF as an important
predictor of POAF is also supported by a study of Ahlsson et al.
12
who recently published the remarkable ﬁnding that one-fourth of
patients with POAF developed AF of any form during a follow-up
of 5 years. A possible explanation is that these patients already had
a pre-existing substrate for AF at the time of surgery, that this sub-
strate was unmasked by occurrence of acute factors increasing the
activity of pro-arrhythmic factors in the perioperative period and
eventually led to a non-surgical form of AF later on. The hypothe-
tical relationship between acute and chronic factors is illustrated in
Figure 2. In this ﬁgure, the time course of two hypothetical patients
is depicted. Both patients have no AF history at the time of surgery
and undergo on-pump CABG at the same age. In patient 1, acute
surgery-related factors enhance the AF susceptibility, but the ‘AF
threshold’
161 is not reached and sinus rhythm is maintained in
the post-operative phase. In patient 2, synergistic interaction of
acute, surgery-induced factors and the pre-existence of a substrate
for AF due to structural heart disease enhances AF susceptibility
that much that the ‘AF threshold’
161 is exceeded. In this sense,
the post-operative setting can be regarded as a ‘stress test’ for
the propensity to the arrhythmia.
Risk factors for POAF and the
development of an AF substrate
After having discussed the mechanisms predisposing to POAF, this
section describes the relation between these mechanisms and clini-
cal risk factors for AF and POAF.
Age
Advancing age correlates strongly with the occurrence of new
onset AF
162,163 and POAF.
1,2,4,6–9,15–18,44–48 Moreover, several
arguments support that ageing enhances the development of a sub-
strate capable of perpetuating AF.
149 As discussed above, ageing
goes along with ﬁbrosis
151,153,164 and is associated with slowing
of conduction.
165 Surprisingly, in one study endocardial AF induci-
bility in patients without any AF history did not increase with age
and even decreased in elderly patients (.70 years).
166 These older
patients had a signiﬁcant longer AERP compared with younger
patients (40 years). However, as wavelength, measured as the
product of conduction velocity and ERP, is a more reliable predic-
tive index for induction of atrial arrhythmias than conduction vel-
ocity or ERP alone,
167 the pro-arrhyhtmic effect of slowing of
conduction likely outweighs the protective effect of prolongation
of atrial refractoriness.
Structural heart disease
Left atrial enlargement, mitral valve disease, congestive heart
failure, and hypertension are well-known risk factors for non-
surgical AF.
162,163,168 Atrial structural remodelling consequent to
these risk factors can predispose to the onset of POAF. Indeed,
in large epidemiological studies,
2,4,17 these risk factors are also
associated with the incidence of POAF. This suggests that under-
lying mechanisms enhance the propensity to AF similarly in
cardiac surgery patients as in patients not undergoing cardiac
surgery. However, it appears that the association of structural
heart disease with POAF is weaker than with persistent non-
surgical AF.
1,8,9,47 It can be hypothesized that in the case of non-
surgical AF, structural alterations enhanced the development of
an AF substrate so far that AF occurs ‘spontaneously’. In the
setting of POAF, however, superimposition of acute
surgery-induced factors is required to exceed the ‘AF threshold’.
As such, a weaker association would be expected between these
risk factors and POAF incidence compared with non-surgical AF
incidence.
Left atrial enlargement and mitral valve disease
Chronic structural alterations in the left atrium, rather than
changes in ion channels, seem responsible for the higher POAF
susceptibility in patients with enlargement of the left atrium. In
non-AF patients with mitral regurgitance, prolongation rather than
shortening of AERP is seen in the left atrium.
169 Moreover, a line
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the posterior left atrium.
170 In patients with greater left atrial enlar-
gement, this line of block is more extensive compared with ‘unre-
modelled’ patients. Furthermore, complex-fractionated
electrograms, which can be found at a line of block, are relatively
stable in this region and thus most likely related to the underlying
architecture of the atrial wall.
169 Finally, also experimental data
support this rationale. In a canine study of chronic left atrial dilata-
tion due to mitral regurgitation, persistence of induced AF went
hand in hand with the degree of left atrial dilatation.
171 Histological
analysis of these atria revealed areas of chronic inﬂammation and
increased interstitial ﬁbrosis.
171
Congestive heart failure
Congestive heart failure is known to cause (i) left atrial dilatation
due to increased atrial ﬁlling pressures secondary to decreased
ventricular function, (ii) increased atrial ﬁbrosis, and (iii) regional
conduction abnormalities.
172,173
Hypertension
Elevated blood pressure causes left ventricular hypertrophy, left
atrial dilatation, and modiﬁcations of atrial mechanical function,
all promoting AF.
174 However, administration of angiotensin-
converting enzyme inhibitor or angiotensin receptor blocker has
not yet been clearly associated with a decrease in POAF
incidence.
91,175,176
History of atrial ﬁbrillation
High propensity to POAF in patients with previous episodes of AF
is not surprising
3,6. The fact that spontaneous episodes of AF
already occurred shows that the activity of pro-arrhythmic mech-
anisms in these patients exceeded the ‘AF threshold’.
161 Superim-
position of acute surgery-induced factors will only facilitate new
episodes of the arrhythmia. On the other hand, AF itself might
have contributed to the development of an AF substrate secondary
to electrical and structural remodelling of the atria.
Risk factors for atrial ﬁbrillation but not for post-operative
atrial ﬁbrillation
Some but not all studies identiﬁed diabetes as independent risk
factor for AF.
162,163,177,178 Also in POAF, the predictive value of
diabetes for the incidence of the arrhythmia is low.
1–4,6–8,15,17,47
In a recent meta-analysis reviewing 100 217 patients, no difference
in POAF incidence was found between patients with and without
diabetes.
179 Furthermore, men have a 1.5 times greater likelihood
of developing new onset AF compared with women.
162 The mech-
anism behind the higher AF susceptibility remains unclear. In POAF,
male gender fails to reach signiﬁcance in many studies,
1–3,6,7,15,17
and in studies that ﬁnd male gender to be associated with POAF,
the number of women included is often low.
4,8,47,48 Association
between chronic obstructive pulmonary disease (COPD) and new
onset AF is still under discussion.
162,178 COPD has been identiﬁed
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Figure 2 Time course of substrate development and surgery-related factors in the occurrence of atrial ﬁbrillation. Time course of
pro-arrhythmic mechanisms is depicted in two hypothetical patients undergoing cardiac surgery. Both chronic as well as acute factors
related to the operation on day 0 are shown. When the intensity of pro-arrhythmic factors reaches a certain threshold,
161 atrial ﬁbrillation
will occur. Patient 1 has no relevant cardiovascular history, only hypertension (green) at the age of 57. Patient 2 already developed hypertension
(red) at a younger age, followed by diabetes (red), mitral regurgitation (red), and COPD (red) at an older age, respectively. Both patients have
no history of AF and undergo on-pump coronary artery bypass grafting at the same age. However, patient 2 has developed an AF substrate by
the time of operation due to above mentioned cardiovascular diseases. Acute, surgery-related factors occur in both patients: cardiopulmonary
bypass (CPB, yellow), inﬂammation (CRP, purple), oxidative stress (yellow), and sympathetic activation (yellow). Patient 2 develops post-
operative atrial ﬁbrillation (exceeds the ‘AF threshold’), while patient 1 remains with sinus rhythm. AF, atrial ﬁbrillation; COPD, chronic obstruc-
tive pulmonary disease.
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180Intheoccurrence
of POAF, COPD is often identiﬁed as a risk factor.
1–3,9,47 The
pathogenesis of AF in patients with COPD is unclear,
3 but pulmon-
ary hypertension, inﬂammation, hypoxia, acidosis, and right atrial
andventriculardilatationmightcontributetotheformationofasub-
strate for AF in these patients.
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Conclusions
Fromthenumerousexperimentalandepidemiologicalstudiesaddres-
sing the mechanisms of POAF several conclusions can be drawn.
(i) Both transient factors related to surgery as well as
factors developing slowly and progressively contrib-
ute to the occurrence of POAF.
The time course of POAF
4,7,43 unmasks the importance of
temporary surgery-induced factors as inﬂammation, sympath-
etic stimulation, and oxidative stress. However, transient
factors cannot be the only responsible mechanism for the
occurrence of the arrhythmia, as many patients in whom
one or even several of these factors are clearly operative
do not develop POAF.
(ii) Among the transient predisposing mechanisms of
POAF, sympathetic activation appears to be more rel-
evant than inﬂammation and oxidative stress.
Withdrawal from and treatment with b-blockers has been
shown to largely affect POAF incidence,
50,117–119 while redu-
cing oxidative stress,
124,135 or inﬂammation
86,87 were less
effective. In line with this the 2010 European Society of
Cardiology guidelines recommend b-blocker treatment as
ﬁrst-line therapy of POAF.
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(iii) Occurrence of POAF is strongly determined by the
pre-existence of an AF substrate.
Despite the importance of transient surgery-induced factors,
the majority of POAF cases occur in atria with a pre-existing
AF substrate due to a long-lasting structural remodelling
process. Moreover, patients developing POAF have an eight-
fold increased risk of developing AF in the future.
12 If transient
factors were the only cause of onset of POAF, AF after
surgery would not be expected to be associated with occur-
rence of AF later on. This emphasizes the important role for
more chronic factors, not directly related to surgery.
(iv) AF after cardiac surgery and non-surgical AF have
common clinical risk factors.
Patients developing AF after surgery have pre-operatively
increased intra-atrial conduction times (longer signal-averaged
P-wave duration)
159 and more profound atrial structural
changes like ﬁbrosis
148,153 compared with patients who main-
tain sinus rhythm after surgery. This presence of structural
‘remodelling’ of atria before the onset of POAF is very
similar to the setting of non-surgical AF. In agreement with
this hypothesis, the risk factors for POAF are surprisingly
similar to the classical risk factors identiﬁed for AF as such.
(v) Susceptibility to AF after surgery is not to due to
changes in ionic currents.
In non-surgical AF, alterations in ion channels as a conse-
quence of AF enhance the perpetuation of AF.
143,145–147
However, the function of these ion channels is not altered
in pre-operative atrial biopsies of patients developing AF
after cardiac surgery.
50,145,147,148
(vi) Progress in the preventive treatment of POAF has
been made during the past decade.
As age is the strongest risk factor for POAF
1,2,4,6–9,15–18,44–48
and cardiac surgery nowadays is performed in older
patients,
49 one would expect POAF incidence to rise over
time. The fact that recent epidemiological studies
10,17 were
not able to conﬁrm this trend suggests signiﬁcant progress
in preventive treatment of POAF.
Reviewing mechanisms predisposing to the occurrence of AF after
cardiac surgery clearly reveals that the pathogenesis of POAF is
multifactorial. Therefore, subclassiﬁcation of POAF based on
these mechanisms does not appear adequate. Identifying leading
mechanisms in individual patients, however, might improve treat-
ment in the future. The clinical setting of POAF offers numerous
opportunities to study not only mechanisms of POAF but also of
AF in general, as cardiac surgery enables direct access to the
heart. This opportunity appears to be underused so far.
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